{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:21:34Z","timestamp":1794439294982,"version":"4.9.1"},"reference-count":117,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/14656566.2025.2551636","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T01:44:07Z","timestamp":1756172647000},"page":"1379-1397","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["The place of risperidone in situ microparticles (ISM\u00ae) among long-acting injectable antipsychotics in schizophrenia treatment"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-1224","authenticated-orcid":false,"given":"Renato","family":"de Filippis","sequence":"first","affiliation":[{"name":"University Magna Graecia of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"University Magna Graecia of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Liparota","sequence":"additional","affiliation":[{"name":"University Magna Graecia of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scaramuzzino","sequence":"additional","affiliation":[{"name":"University Magna Graecia of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2003-2101","authenticated-orcid":false,"given":"Andrea","family":"Aguglia","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"IRCCS Ospedale Policlinico San Martino","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-340X","authenticated-orcid":false,"given":"Andrea","family":"Amerio","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"IRCCS Ospedale Policlinico San Martino","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-856X","authenticated-orcid":false,"given":"Gianluca","family":"Serafini","sequence":"additional","affiliation":[{"name":"University of Genoa","place":["Genoa, Italy"]},{"name":"IRCCS Ospedale Policlinico San Martino","place":["Genoa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"De Fazio","sequence":"additional","affiliation":[{"name":"University Magna Graecia of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.58304"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2024.01.035"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60239-6"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.38358"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0317"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253241280046"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.2076"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13040577"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1910674"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00039-0"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01997-8"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253231157219"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2024.03.003"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20972"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116455"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02175-z"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000040"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02299-8"},{"key":"e_1_3_5_21_1","unstructured":"Risperidone product label. 1993."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05809-8"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.817276"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83570-w"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15692"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000540689"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000477153"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.874705\/full"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12493"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14304"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.3.414"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbad089"},{"key":"e_1_3_5_33_1","first-page":"13","article-title":"The pharmacokinetics of risperidone in humans: a summary","volume":"55","author":"Heykants J","year":"1994","unstructured":"Heykants J, Huang ML, Mannens G, et al. The pharmacokinetics of risperidone in humans: a summary. J Clin Psychiatry [Internet]. 1994;55(Suppl):13\u201317. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7520903","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.07.026"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2434"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-016-0736-z"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-116492"},{"key":"e_1_3_5_38_1","first-page":"1263","article-title":"Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes","volume":"29","author":"Yasui-Furukori N","year":"2001","unstructured":"Yasui-Furukori N, Hidestra Nd M, Spina E, et al. Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. Drug Metab Dispos [Internet]. 2001;29:1263\u20131268. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11560868","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0806b"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c17df0"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30088-4"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881104042618"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181863239"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.49.4.347"},{"key":"e_1_3_5_45_1","first-page":"S80","article-title":"Pharmacological profile of risperidone","volume":"38","author":"Ereshefsky L","year":"1993","unstructured":"Ereshefsky L, Lacombe S. Pharmacological profile of risperidone. Can J Psychiatry [Internet]. 1993;38 Suppl 3:S80\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7504573","journal-title":"Can J Psychiatry"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12295"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.02.017"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)29327-7"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519050-00005"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.1.64"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500211"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.6.748"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-009-0039-0"},{"key":"e_1_3_5_54_1","first-page":"18","article-title":"Efficacy of risperidone on positive features of schizophrenia","volume":"55","author":"McEvoy JP","year":"1994","unstructured":"McEvoy JP. Efficacy of risperidone on positive features of schizophrenia. J Clin Psychiatry [Internet]. 1994;55(Suppl):18\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7520904","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(94)00127-W"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920008784746373"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-6757(98)90001-8"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-015-0092-x"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125320937575"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2024.152496"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.4.514"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-022-00402-5"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240321"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02694-3"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704004924"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2022.10.270"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00779-5"},{"key":"e_1_3_5_68_1","volume-title":"Modecate (fluphenazine decanoate) injection","author":"App Pharmaceuticals L","year":"2017","unstructured":"App Pharmaceuticals L. Modecate (fluphenazine decanoate) injection. USP; 2017."},{"key":"e_1_3_5_69_1","volume-title":"Haldol decanoate (haloperidole decanoate)","author":"Janssen Pharmaceuticals I","year":"2011","unstructured":"Janssen Pharmaceuticals I. Haldol decanoate (haloperidole decanoate). Product Label; 2011."},{"key":"e_1_3_5_70_1","volume-title":"Risperdal consta (risperidone) long acting injection","author":"Janssen Pharmaceuticals I","year":"2003","unstructured":"Janssen Pharmaceuticals I. Risperdal consta (risperidone) long acting injection. Product Label; 2003."},{"key":"e_1_3_5_71_1","unstructured":"Otsuka Pharmaceutical C. Abilify Asimtufii\u00ae (aripiprazole) extended-release injectable suspension for intramuscular use. 2023."},{"key":"e_1_3_5_72_1","unstructured":"Alkermes I. Aristada Initio\u00ae (aripiprazole lauroxil) extended-release injectable suspension for intramuscular use. 2025."},{"key":"e_1_3_5_73_1","unstructured":"Indivior Inc. Risperidone once-monthly (Perseris\u00ae) for extended-release injectable suspension. 2018."},{"key":"e_1_3_5_74_1","unstructured":"Lundbeck standard. CLOPIXOL\u00ae depot 200 mg\/mL zuclopenthixol intramuscular injection (144.4 mg\/mL zuclopenthixol as zuclopenthixol decanoate). Product Label."},{"key":"e_1_3_5_75_1","volume-title":"Abilify Maintena (aripiprazole) extended-release injectable suspension","author":"Otsuka Pharmaceutical C","year":"2013","unstructured":"Otsuka Pharmaceutical C. Abilify Maintena (aripiprazole) extended-release injectable suspension. Product Label.; 2013."},{"key":"e_1_3_5_76_1","volume-title":"Aristada (aripiprazole lauroxil) extended-release injectable suspension","author":"Alkermes I","year":"2015","unstructured":"Alkermes I. Aristada (aripiprazole lauroxil) extended-release injectable suspension. Product Label.; 2015."},{"key":"e_1_3_5_77_1","unstructured":"Eli Lilly and C. Zyprexa Relprevv (olanzapine) extended-release injectable suspension. Product label. 2009."},{"key":"e_1_3_5_78_1","article-title":"Invega Sustenna (paliperidone palmitate) extended-release injectable suspension","author":"Janssen Phamaceuticals I","year":"2009","unstructured":"Janssen Phamaceuticals I. Invega Sustenna (paliperidone palmitate) extended-release injectable suspension. Prod Label. 2009.","journal-title":"Prod Label"},{"key":"e_1_3_5_79_1","unstructured":"Janssen Pharmaceuticals I. Invega Trinza (paliperidone palmitate) extended-release injectable suspension. 2017 Feb;2015."},{"key":"e_1_3_5_80_1","article-title":"Invega Hafyera (paliperidone palmitate) extended-release injectable suspension","author":"Janssen Pharmaceuticals I","year":"2021","unstructured":"Janssen Pharmaceuticals I. Invega Hafyera (paliperidone palmitate) extended-release injectable suspension. Prod Label. 2021.","journal-title":"Prod Label"},{"key":"e_1_3_5_81_1","first-page":"198","article-title":"Lipid profile in antipsychotic drug users: a comparative study","volume":"9","author":"Roohafza H","year":"2013","unstructured":"Roohafza H, Khani A, Afshar H, et al. Lipid profile in antipsychotic drug users: a comparative study. ARYA atheroscler [Internet]. 2013;9:198\u2013202. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23766777","journal-title":"ARYA atheroscler"},{"key":"e_1_3_5_82_1","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri MC","year":"2014","unstructured":"Mauri MC, Paletta S, Maffini M, et al. Clinical pharmacology of atypical antipsychotics: an update. Excli J [Internet]. 2014;13:1163\u20131191. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26417330","journal-title":"Excli J"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16010028"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2024.2370349"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2025.2474126"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.144"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009355156"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200411000-00009"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-6-3"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0295-2"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.366"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0132-7"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.141"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00762-0"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000203"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-020-00127-y"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S332026"},{"key":"e_1_3_5_98_1","unstructured":"ROVI Pharma Industrial Services. Okedi\u00ae (risperidone). Product Label; 2022."},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020384"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119889296"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02140-2"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.696143"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.739708"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-023-00464-z"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.16121358"},{"issue":"8","key":"e_1_3_5_106_1","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","volume":"2020","author":"Ceraso A","year":"2020","unstructured":"Ceraso A, Lin JJ, Schneider-Thoma J, et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev. 2020;2020;8(8).","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0311"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(00)00536-8"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200503000-00002"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-004-0556-4"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1159\/000054932"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15032su1"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2023.2220962"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.767756"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2020.1737134"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12278"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-022-00430-1"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00779-5"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116124"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2025.2551636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:34:24Z","timestamp":1759480464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2025.2551636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":117,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/14656566.2025.2551636"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2025.2551636","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}